Senti bio to present at live! with webull corporate connect: virtual biotech investment webinar

South san francisco, calif., may 22, 2025 (globe newswire) -- senti biosciences, inc. (nasdaq: snti) (“senti bio” or the “company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary gene circuit platform, today announced that timothy lu, m.d.
LIVE Ratings Summary
LIVE Quant Ranking